ATE55108T1 - Verfahren zur behandlung von gicht mit chalconderivaten. - Google Patents

Verfahren zur behandlung von gicht mit chalconderivaten.

Info

Publication number
ATE55108T1
ATE55108T1 AT88105541T AT88105541T ATE55108T1 AT E55108 T1 ATE55108 T1 AT E55108T1 AT 88105541 T AT88105541 T AT 88105541T AT 88105541 T AT88105541 T AT 88105541T AT E55108 T1 ATE55108 T1 AT E55108T1
Authority
AT
Austria
Prior art keywords
gout
treatment
inhibit
reported
derivatives
Prior art date
Application number
AT88105541T
Other languages
English (en)
Inventor
Michael L Edwards
David M Stemerick
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE55108T1 publication Critical patent/ATE55108T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Saccharide Compounds (AREA)
AT88105541T 1987-04-09 1988-04-07 Verfahren zur behandlung von gicht mit chalconderivaten. ATE55108T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3621487A 1987-04-09 1987-04-09
EP88105541A EP0287901B1 (de) 1987-04-09 1988-04-07 Verfahren zur Behandlung von Gicht mit Chalcon-Derivaten

Publications (1)

Publication Number Publication Date
ATE55108T1 true ATE55108T1 (de) 1990-08-15

Family

ID=21887305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88105541T ATE55108T1 (de) 1987-04-09 1988-04-07 Verfahren zur behandlung von gicht mit chalconderivaten.

Country Status (10)

Country Link
EP (1) EP0287901B1 (de)
KR (1) KR880012529A (de)
AT (1) ATE55108T1 (de)
AU (1) AU608821B2 (de)
DE (1) DE3860376D1 (de)
ES (1) ES2016865B3 (de)
GR (1) GR3000689T3 (de)
IE (1) IE60734B1 (de)
PH (1) PH24634A (de)
ZA (1) ZA882388B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54152091A (en) * 1978-05-22 1979-11-29 Fuji Photo Film Co Ltd Photopolymerizable composition
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
CA1168659A (fr) * 1980-08-06 1984-06-05 Gerard Lang Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant

Also Published As

Publication number Publication date
IE881076L (en) 1988-10-09
ZA882388B (en) 1988-09-22
KR880012529A (ko) 1988-11-28
PH24634A (en) 1990-08-17
AU1416588A (en) 1988-10-13
EP0287901B1 (de) 1990-08-01
DE3860376D1 (de) 1990-09-06
GR3000689T3 (en) 1991-09-27
ES2016865B3 (es) 1990-12-01
EP0287901A1 (de) 1988-10-26
IE60734B1 (en) 1994-08-10
AU608821B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
DE3882771D1 (de) Verfahren zur behandlung von multipler sclerose mit chalkonderivaten.
ATE106723T1 (de) Kontrolle der entwicklung von gewebetumoren mit chalcon-derivaten.
ATE94069T1 (de) Verwendung von physiologisch wirksamen substanzen zur herstellung von medikamenten fuer gehirn- und nervenerkrankungen.
ATE153696T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
ATE88890T1 (de) D-cycloserin und d-alanin enthaltende mischung zur verbesserung des gedaechtnisses und des lernvermoegens oder zur behandlung von kognitiven und psychotischen erkrankungen.
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
DE69121561D1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
DE3885151D1 (de) Methode zur Herstellung von Methacrylatestern.
DE3855527D1 (de) Doppelsträngige RNS zur Korrektur von Abnormalitäten von zirkulierenden Immunkomplexen und der Monozytenfunktion
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE68916266D1 (de) Methode zur Herstellung und Stabilisierung von Halosilanen mit Acrylfunktionen.
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE55108T1 (de) Verfahren zur behandlung von gicht mit chalconderivaten.
ATE142689T1 (de) Verfahren zur herstellung von aktiviertem protein c
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee